Jarinoxa 40mg Injection
Marketer
Jarita Biotech
Salt Composition
Enoxaparin (40mg)
Overview Jarinoxa 40mg Injection
Anticoagulant therapy with Xyloderm 40mg Injection prevents and manages dangerous blood clots. This medication inhibits clot growth and formation, mitigating the risk of deep vein thrombosis and pulmonary embolism. Administered subcutaneously by a healthcare professional (never intramuscularly), dosage and duration are individualized, considering your health status, response to treatment, age, and weight. Continued use, even without noticeable symptoms, is crucial to prevent future complications; discontinuation may lead to clot formation. Avoid activities increasing bleeding or injury risk while on this medication. Common side effects include injection site discomfort, bleeding, headache, elevated platelet count, respiratory difficulties, swelling, anemia, fever, diarrhea, and increased liver enzymes. Severe headache or abdominal pain may indicate internal bleeding, a potentially serious, and sometimes subtle, complication. Report any concerning symptoms immediately. Prior to treatment, disclose any history of hypertension, diabetes, or recent stroke. This medication is contraindicated with active bleeding. Inform your physician of all other medications to ensure compatibility. Patients with low body weight or those who consume alcohol may experience a heightened bleeding risk, particularly gastrointestinal bleeding.
Primary Ingredients of Jarinoxa 40mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Jarinoxa 40mg Injection
Managing and averting blood clot formation
Major Benefits of Jarinoxa 40mg Injection:
Administering this medication will be done by your healthcare provider; please do not attempt self-medication.
Common Side effects of Jarinoxa 40mg Injection:
- Bleeding
- Headache
- Low blood platelets
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Fever
- Injection site pain
- Breathing problems
- Edema (swelling)
- Diarrhea
How to use Jarinoxa 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Jarinoxa 40mg Injection works:
Jarinoxa 40mg Injection is a medication that thins the blood. Its mechanism involves neutralizing specific coagulation factors, thus inhibiting clot development and mitigating vascular obstructions.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Jarinoxa 40mg Injection may pose safety risks; seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable form of Jarinoxa, 40mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; however, corresponding data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Jarinoxa 40mg Injection during breastfeeding is likely safe. Available data from humans indicates minimal risk to the infant. The drug's transfer into breast milk is negligible, resulting in insignificant quantities reaching the baby, posing no foreseeable harm.
DrivingSAFE
Driving ability is typically unaffected by Jarinoxa 40mg Injection.
KidneyCAUTION
Patients with kidney impairment should use Jarinoxa 40mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Jarinoxa 40mg Injection's use in individuals with hepatic impairment. Physician consultation is recommended. Nevertheless, its administration to patients with pre-existing liver conditions should be approached with prudence.
What if you forget to take Jarinoxa 40mg Injection :
Should you forget a scheduled dose of Jarinoxa 40mg Injection, seek immediate medical advice.
Facts to Know About Jarinoxa 40mg Injection
| Label | Value |
|---|---|
| Chemical Category | Low-molecular-weight heparin |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Low-molecular-weight heparin (LMWH) |
3,018 People bought this recently